
Current Price | $21.94 | Mkt Cap | $6.8B |
---|---|---|---|
Open | $21.83 | P/E Ratio | 78.19 |
Prev. Close | $21.94 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.63 - $21.98 | Volume | 1,854,533 |
52-Wk Range | $15.32 - $22.80 | Avg. Daily Vol. | 2,289,904 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
Current Price | $21.94 | Mkt Cap | $6.8B |
---|---|---|---|
Open | $21.83 | P/E Ratio | 78.19 |
Prev. Close | $21.94 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $21.63 - $21.98 | Volume | 1,854,533 |
52-Wk Range | $15.32 - $22.80 | Avg. Daily Vol. | 2,289,904 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong revenue growth and a oncology portfolio that is growing.
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
Strong revenue growth and a oncology portfolio that is growing.
Recs
From Fidelity or Zacks November 2021:
Revenue Growth (Last 5 Years) = 92.7%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 42.1%
Price/Sales (TTM) = 5.2
Recs
First one i picked all by myself, reason:
1. Mkt Cap 7.39B plenty place to grow
2. EPS nxt Yr 94.84%
3.EPS nxt 5Yr 46.00%
4. Sales past 5Yr 107.60%
5. Dept/ Equity 0
Issues:
1. High insider transactions almost 30%
2. Company works on cure for cancer - high volatility
3. EPS this Y -53.80% but justified by Covid-19
Practice and enjoy!
Find the members with the highest scoring picks in EXEL.
beave35 (94.10) Score: +1,463.37
The Score Leader is the player with the highest score across all their picks in EXEL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Playa14 | < 20 |
|
![]() |
5Y | $1.27 | +1,624.02% | +120.39% | +1,503.62 | 0 Comment | |
beave35 | 94.10 | 12/23/2014 |
![]() |
5Y | $1.30 | +1,584.10% | +120.73% | +1,463.37 | 0 Comment | |
tomkao | < 20 | 12/15/2014 |
![]() |
5Y | $1.40 | +1,463.93% | +127.75% | +1,336.18 | 0 Comment | |
jack0071 | 64.37 | 12/3/2014 |
![]() |
5Y | $1.43 | +1,431.12% | +121.47% | +1,309.65 | 0 Comment | |
portefeuille | 97.96 |
|
![]() |
NS | $1.44 | +1,420.49% | +127.30% | +1,293.19 | 0 Comment | |
akoniec | < 20 | 10/9/2014 |
![]() |
3Y | $1.55 | +1,312.58% | +133.84% | +1,178.74 | 0 Comment | |
dcoyne13 | 46.01 | 9/16/2014 |
![]() |
5Y | $1.62 | +1,251.46% | +129.66% | +1,121.79 | 0 Comment | |
foolerhoff | 88.19 | 1/6/2015 |
![]() |
5Y | $1.64 | +1,235.06% | +127.18% | +1,107.88 | 0 Comment | |
garisonmp3z | < 20 | 1/5/2015 |
![]() |
5Y | $1.67 | +1,211.08% | +124.86% | +1,086.22 | 0 Comment | |
new2fool23 | 43.85 | 1/5/2015 |
![]() |
1Y | $1.67 | +1,211.08% | +124.86% | +1,086.22 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.